GATA-3
PO
Definition: GATA3 is a zinc-finger transcription factor (ZFNs), which is expressed in various normal and neoplastic tissues.
GATA3 is a transcription factor important in the differentiation of breast epithelia, urothelia, and subsets of T-lymphocytes.
It has been suggested useful in the evaluation of mammary or urothelial origin or metastatic carcinomas. GATA3 is a useful marker in characterization not only mammary carcinomas and urothelial carcinoma but also for renal tumors (...)
Home > Keywords > Proteins > Overexpressed in tumors
Overexpressed in tumors
Articles
-
GATA3
24 May 2005 -
PRAME
14 juin 2007PRAME is a gene encoding an antigen recognized on a human melanoma by cytolytic T cells.
Human tumor antigens recognized by autologous cytolytic T lymphocytes (CTLs) include 3 classes of proteins : those expressed in tumors but not in normal tissues other than placenta or testis (like MAGE1 ; MIM.300016) ; differentiation antigens expressed in melanocytes or melanomas (like melan-A ; MIM.605513) ; and antigens resulting from point mutations in ubiquitously expressed genes (like MUM1 ; (...) -
WSB1
1 May 2007SWIP1
-
AKT2
2 February 2007Definition: AKT2 (MIM.164731) is the isoform of AKT 1 and is enriched in insulin-responsive tissues and has been implicated in the metabolic actions of the hormone.
Pathology
An activating mutation of AKT2 and human hypoglycemia. (#21979934#)
AKT2 mutations and/or amplification in tumors ovarian carcinomas (#16839745#, #16721043#) pancreatic carcinomas (#14735903#) mammary carcinomas (#12032855#) embryonal rhabdomyosarcoma (#16790082#)
See also
AKTs
References
An activating (...) -
MYB
3 September 2007V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG
Pathology
MYB overexpression in colorectal cancer (CRC) is a prognostic indicator for poor survival.
MYB duplication by dup(6)(q22-q23) in acute lymphoblastic leukemia (ALL)
MYB-GATA1 fusion gene in acute basophilic leukemia (#21474671#)
MYB-NFIB fusion gene in cystic carcinoma (ACC) mammary adenoid cystic carcinoma (MACC) salivary adenoid cystic carcinoma (MACC)
Open References
Identification of a transforming MYB-GATA1 fusion (...) -
KIF14
6 September 2007KIF14 is a member of the kinesin superfamily of microtubule-associated motors (KIFs) that play important roles in intracellular transport and cell division.
Pathology
located in 1q32.1 amplification (62%) (positively associated with 6p gain and maybe MYCN gain) (#17099872#)
KIF14 (kinesin family member 14) is an overexpressed candidate oncogene in the 1q31.3-1q32.1 minimal region of genomic gain in breast cancer cell lines.
KIF14 overexpression is a negative predictor of grade and (...) -
COL4A2
6 September 2007Pathology
COL4A2 is overexpressed in glioblastoma multiforme (#17002787#)
References
Ruano Y, Mollejo M, Ribalta T, Fiano C, Camacho FI, Gomez E, de Lope AR, Hernandez-Moneo JL, Martinez P, Melendez B. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer. 2006 Sep 26;5:39. PMID: (...) -
STIM2
6 September 2007STIM2 is an inhibitor of STIM1 (MIM.605921)-mediated store-operated Ca(2+) (SOC) entry.
Pathology
STIM2 is overexpressed in glioblastoma multiforme (#17002787#)
References
Ruano Y, Mollejo M, Ribalta T, Fiano C, Camacho FI, Gomez E, de Lope AR, Hernandez-Moneo JL, Martinez P, Melendez B. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer. 2006 Sep 26;5:39. PMID: (...) -
IRX2
11 September 2007IRX2 is a member of the Iroquois homeobox gene family IRXs. Members of IRXs family appear to play multiple roles during pattern formation of vertebrate embryos.
Pathology
Copy number gains and high-level amplifications of the short arm of chromosome 5 are frequently observed in soft tissue sarcomas.
amplified and overexpressed in MPNST (#16752383#)
See also
TRIO
NKD2 (overexpressed in MPNSTs)
References
Adamowicz M, Radlwimmer B, Rieker RJ, Mertens D, Schwarzbach M, Schraml P, (...) -
PRDM16
3 September 2007MEL1